about
Interventions to improve adherence to lipid lowering medicationInterventions to improve adherence to lipid lowering medicationPopulation impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart diseaseOptimal lipid modification: the rationale for combination therapyImproving the physician-patient cardiovascular risk dialogue to improve statin adherence.The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medicationIs patient-centered care the same as person-focused care?Promoting knowledge of statins in patients with low health literacy using an audio booklet.Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyAssociation between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.Initial phase of chronic medication use; patients' reasons for discontinuationThe roles of past behavior and health beliefs in predicting medication adherence to a statin regimenManagement of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.Patient characteristics associated with medication adherence.Impact of drugs counselling by an undergraduate pharmacist on cardiac surgical patient's compliance to medicines.Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?Sex and gender influences on pharmacological response: an overview.Who cares? The James Mackenzie Lecture 2006.Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients.Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong.Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy.Age and medication acceptance.The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).Assessment of adherence measures with different stimulants among children and adolescents.Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes.
P2860
Q24236817-A1A370DB-BFFD-4D6D-B03B-32ED50BEB26DQ24245739-B4DA14E2-E60E-4909-913C-7C22BD8EF48BQ24682494-6EE6C488-6FD7-430E-9348-DBB8C1BC3894Q28219266-B6E213A5-9159-4F35-96CF-E0CC74414924Q33476545-81B0D713-AB10-4AF6-8E49-8459517A95F7Q34042008-12AB9273-906D-404E-8FBD-85AD128BE1FDQ35119459-7E7A607B-58DC-4404-8E6F-289B34A85A8FQ35221697-5EE721E3-A1BD-4591-AAE0-5D9210CED4A6Q35580390-471F9468-B8A1-45A3-A02C-BD7F8FDDBBD4Q35826483-9FCF2EC2-02B2-4254-AD84-7E142CE11E4AQ35827473-0E068BBB-ADCF-408E-A1C3-A6C69B5AFD8BQ36289295-0E294364-AB7D-46C3-B7C9-565D2C4546CAQ36906018-6EB6CB66-C347-4682-8271-1593EB4A0726Q36954729-22624252-5845-4455-B250-7A97D43CB6EDQ37408282-C24BBCC7-AFB9-4A41-B634-FCC4AB57AB0DQ37423691-0E4261E1-FD38-4DE6-A8B5-4B28D6A633A5Q38214338-9D7CA411-F253-4137-B2F0-0C29E182B65AQ42724848-CF8FCB98-FE07-4C6D-B02D-35392F85B28DQ44236160-CA23FF08-580F-451D-A07D-7DDA9D099BC2Q44746157-A6EECDBF-3DA3-4AC7-A19F-3B9D15C596E0Q44897904-F627DC28-0453-44B9-A8F9-92301A1D013DQ44907869-5720C833-5A46-4B39-A195-59A8A4540104Q45108986-24E880EE-6900-44D5-90BA-5CE19FD1077EQ46382292-0580134B-40C8-4C65-A834-6A1F186E49FAQ46592039-A9D3BB5A-E988-4F54-9FAD-E61999476FE1Q47720132-AA3DF792-4BC0-425C-BF48-C25606107463
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Enhancing drug compliance in lipid-lowering treatment.
@ast
Enhancing drug compliance in lipid-lowering treatment.
@en
Enhancing drug compliance in lipid-lowering treatment.
@nl
type
label
Enhancing drug compliance in lipid-lowering treatment.
@ast
Enhancing drug compliance in lipid-lowering treatment.
@en
Enhancing drug compliance in lipid-lowering treatment.
@nl
prefLabel
Enhancing drug compliance in lipid-lowering treatment.
@ast
Enhancing drug compliance in lipid-lowering treatment.
@en
Enhancing drug compliance in lipid-lowering treatment.
@nl
P1476
Enhancing drug compliance in lipid-lowering treatment.
@en
P2093
P304
P356
10.1001/ARCHFAMI.9.10.1169
P577
2000-11-01T00:00:00Z